Page last updated: 2024-12-06

perfluorobutane sulfonate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Perfluorobutane sulfonate (PFBS) is a synthetic perfluorinated alkyl sulfonate (PFAS) that has been widely used in various industrial and consumer products. It is a colorless, odorless, and highly water-soluble compound. PFBS is typically synthesized through a multi-step process that involves the fluorination of butane followed by sulfonation. PFBS has been detected in various environmental matrices, including drinking water, soil, and biota, raising concerns about its potential environmental and health effects. Studies have shown that PFBS can persist in the environment for extended periods and can bioaccumulate in living organisms. Concerns regarding PFBS primarily revolve around its potential toxicity and persistence in the environment. Research on PFBS focuses on understanding its environmental fate, toxicity, and potential health effects. Studies investigate its bioaccumulation, biomagnification, and potential endocrine disruption. Moreover, researchers are exploring the efficacy of various treatment technologies for removing PFBS from contaminated water sources. The research on PFBS aims to provide insights into its environmental behavior, potential risks, and mitigation strategies.'

perfluorobutanesulfonic acid: a surfactant; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

perfluorobutanesulfonic acid : A perfluoroalkanesulfonic acid that is butane-1-sulfonic acid in which all of the hydrogens of the butyl group have been replaced by fluorines. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID67815
CHEMBL ID1198521
CHEBI ID132446
SCHEMBL ID23932
MeSH IDM0521131

Synonyms (45)

Synonym
59933-66-3
NCI60_006096
nonafluorobutanesulfonic acid
einecs 206-793-1
1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulphonic acid
1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfonic acid
nonafluoro-1-butanesulfonic acid
1-butanesulfonic acid, 1,1,2,2,3,3,4,4,4-nonafluoro-
nonafluorobutane-1-sulfonic acid, 97%
1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonic acid
375-73-5
1-perfluorobutanesulfonic acid
perfluorobutanesulfonic acid
perfluorobutane-1-sulfonic acid
CHEBI:132446
nonafluorobutane-1-sulfonic acid
pfbs
fc-98
perfluoro-1-butanesulfonic acid
N0709
1fv02n6nvo ,
hsdb 8294
1-butanesulfonic acid, nonafluoro-
unii-1fv02n6nvo
CHEMBL1198521
perfluorobutyl sulfonic acid
nonafluorobutanesulphonic acid
perfluorobutane sulfonic acid
FT-0676859
FT-0676348
perfluorobutanesulphonic acid
AKOS015852768
SCHEMBL23932
CS-B0899
nonafluorobutane sulfonic acid
butanesulfonic acid, nonafluoro-
DTXSID5030030 ,
mfcd01320794
nonafluoro 1-butanesulfonic acid
eftop fbsa
nonafluoro-1-butanesulfonicacid
Q410426
perfluorobutanesulfonic acid 100 microg/ml in methanol/water
dyyxillzbjctsf-uhfffaoysa-n
D77221

Research Excerpts

Overview

Perfluorobutane Sulfonate (PFBS) is a short-chained PFAS used to replace perfluorooctane sulfonate in commerce.

ExcerptReferenceRelevance
"Perfluorobutane Sulfonate (PFBS) is a short-chained PFAS used to replace perfluorooctane sulfonate in commerce."( Pharmacokinetic profile of Perfluorobutane Sulfonate and activation of hepatic nuclear receptor target genes in mice.
Das, KP; Lau, C; Rumpler, J; Schmid, JE; Strynar, MJ; Wambaugh, JF; Wood, CR, 2020
)
1.58

Effects

ExcerptReferenceRelevance
"Perfluorobutane sulfonate (PFBS) has oily and hydrophobic characteristics similar to those of perfluorooctane sulfonic acid (PFOS), which is an environmental organic pollutant and has gradually become the main substitute for PFOS in industry. "( Molecular and genetic analyses revealed the phytotoxicity of perfluorobutane sulfonate.
Ju, Q; Liu, F; Sun, L; Xu, J; Zhang, P, 2022
)
2.41

Toxicity

ExcerptReferenceRelevance
" In this study, aged zebrafish were first transplanted with the feces from young donors and subsequently exposed to perfluorobutanesulfonate (PFBS), an emerging persistent toxic pollutant."( Young fecal transplantation mitigates the toxicity of perfluorobutanesulfonate and potently refreshes the reproductive endocrine system in aged recipients.
Chen, L; Hu, C; Liu, M; Sun, B; Tang, L; Zhou, X, 2022
)
0.72
" After exposure, toxic effects of PFBS on visual system of aged zebrafish were elucidated based on transcriptional, proteomic, biochemical, histological, and behavioral evidences."( Young fecal transplantation modulates the visual toxicity of perfluorobutanesulfonate in aged zebrafish recipients.
Chen, L; Hu, C; Lam, PKS; Li, J; Liu, M, 2022
)
0.72
" However, regarding gill functions, hypoxic influences and time course progression of toxic effects of PFBS remain unclear."( Toxicity of perfluorobutanesulfonate on gill functions of marine medaka (Oryzias melastigma): A time course and hypoxia co-exposure study.
Chen, L; Giesy, JP; Hu, C; Lam, PKS; Li, J; Sun, B, 2023
)
0.91
"47 μM POD) was approximately 700 times less toxic than PFOS (11."( Integrative multi-omics reveals analogous developmental neurotoxicity mechanisms between perfluorobutanesulfonic acid and perfluorooctanesulfonic acid in zebrafish.
Bae, MA; Kim, KT; Kim, SS; Kim, TY; Lee, H; Lee, S; Min, EK; Seo, SW; Song, M; Sung, EJ; Wang, S, 2023
)
0.91
" In contrast, exposure to 6:2FTSA did not result in adverse transcriptomic effects, suggesting that 6:2FTSA exerted the least molecular-scale toxicity in earthworms."( Are PFBS, PFHxS, and 6:2FTSA more friendly to the soil environment compared to PFOS? A new insight based on ecotoxicity study in soil invertebrates (Eisenia fetida).
Du, Z; Juhasz, A; Li, B; Li, D; Liu, X; Wang, J; Wang, X; Zhang, J; Zhu, L, 2023
)
0.91

Pharmacokinetics

ExcerptReferenceRelevance
" This study evaluated the pharmacokinetic properties of PFBS and its hepatic transcriptional responses in CD-1 mice."( Pharmacokinetic profile of Perfluorobutane Sulfonate and activation of hepatic nuclear receptor target genes in mice.
Das, KP; Lau, C; Rumpler, J; Schmid, JE; Strynar, MJ; Wambaugh, JF; Wood, CR, 2020
)
0.86

Compound-Compound Interactions

ExcerptReferenceRelevance
" To investigate the link between PFAS and prostate cancer, we evaluated the impact of metabolic alterations resulting from a high-fat diet combined with PFAS exposure on prostate tumor progression."( Per- and Polyfluoroalkyl Substance Exposure Combined with High-Fat Diet Supports Prostate Cancer Progression.
Hu, WY; Imir, OB; Irudayaraj, J; Kaminsky, AZ; Liu, YJ; Madak Erdogan, Z; Prins, GS; Singh, R; Spinella, MJ; Zuo, QY, 2021
)
0.62

Dosage Studied

ExcerptRelevanceReference
" Rats were dosed with K+PFBS at doses of 60, 200, and 600mg/kg-day body weight."( Toxicological evaluation of potassium perfluorobutanesulfonate in a 90-day oral gavage study with Sprague-Dawley rats.
Butenhoff, JL; Chang, SC; Lieder, PH; York, RG, 2009
)
0.35
" Parental-generation (P) rats were dosed orally by gavage with 0, 30, 100, 300 and 1000mg K(+)PFBS/kg/day for 10 weeks prior to and through mating (males and females), as well as during gestation and lactation (females only)."( A two-generation oral gavage reproduction study with potassium perfluorobutanesulfonate (K+PFBS) in Sprague Dawley rats.
Butenhoff, JL; Chang, SC; Hakes, DC; Lieder, PH; York, RG, 2009
)
0.35
" There were no apparent differences between genders in the serum half-life for PFHxA following 26 days of repeated oral dosing in rats; exposure decreased upon repeated dosing."( Comparison of the toxicokinetic behavior of perfluorohexanoic acid (PFHxA) and nonafluorobutane-1-sulfonic acid (PFBS) in cynomolgus monkeys and rats.
Chengelis, CP; Kirkpatrick, JB; Myers, NR; Shinohara, M; Stetson, PL; Sved, DW, 2009
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
surfactantA substance which lowers the surface tension of the medium in which it is dissolved, and/or the interfacial tension with other phases, and, accordingly, is positively adsorbed at the liquid/vapour and/or at other interfaces.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
perfluoroalkanesulfonic acidAn organosulfonic acid in which the sulfo group is directly attached to a perfluoroalkyl group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (75)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (4.00)29.6817
2010's19 (25.33)24.3611
2020's53 (70.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 40.29

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index40.29 (24.57)
Research Supply Index4.33 (2.92)
Research Growth Index5.51 (4.65)
Search Engine Demand Index54.24 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (40.29)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other75 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]